Ovarian Cancer Patient Questionnaire on Genetic Testing
NCT00486707 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 237
Last updated 2012-08-01
Summary
The objective of this study is to evaluate the willingness of patients with ovarian cancer to undergo genetic testing, given the cost, their understanding and acceptance of genetic testing and the possibility of targeted therapy.
Conditions
Interventions
- BEHAVIORAL
-
Questionnaire
A questionnaire will be completed.
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Karen H. Lu, MD · M.D. Anderson Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-06-30
- Primary Completion
- 2008-10-31
- Completion
- 2008-10-31
Countries
- United States
Study Locations
More Related Trials
-
A Multivariate Index Assay for Ovarian Cancer Risk Assessment in Women With Adnexal Mass and High-Risk Germline Variants
NCT04487405 ·Status: TERMINATED
-
Appraising Medical Trial Experiences of Ovarian Cancer Patients
NCT05801796 ·Status: NOT_YET_RECRUITING
-
Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer
NCT00003794 ·Status: TERMINATED
-
Pharmacogenomics of Paclitaxel in Ovarian Cancer
NCT00415207 ·Status: COMPLETED
-
M. D. Anderson Symptom Inventory - Ovarian Cancer
NCT01037751 ·Status: COMPLETED
-
Advanced Ovarian Cancer and Sexuality Phase 1
NCT00488202 ·Status: COMPLETED
-
Screening Women at High Genetic Risk for Ovarian Cancer
NCT00033488 ·Status: COMPLETED ·Phase: NA
-
Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
NCT00757263 ·Status: UNKNOWN
-
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
NCT00043472 ·Status: COMPLETED
-
Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors
NCT00488878 ·Status: RECRUITING
-
Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy
NCT00084370 ·Status: WITHDRAWN ·Phase: NA
-
Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases
NCT01048814 ·Status: COMPLETED
-
Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary
NCT00626873 ·Status: COMPLETED ·Phase: PHASE1
-
Interactive Educational Website for Women With Ovarian Cancer & Caregivers
NCT01626014 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Women Surviving Ovarian Cancer
NCT00596349 ·Status: COMPLETED
-
Improving Quality of Care for Patients With Recurrent Ovarian Cancer
NCT02809339 ·Status: UNKNOWN
-
Cost Utility Analysis in Recurrent Ovarian Cancer
NCT00813254 ·Status: WITHDRAWN
-
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
NCT00587093 ·Status: COMPLETED ·Phase: NA
-
Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function
NCT00525460 ·Status: COMPLETED
-
Pharmacogenomics of Paclitaxel in Ovarian Cancer
NCT00415181 ·Status: COMPLETED
-
New Biomarkers Evaluating Ovarian Cancer
NCT01466049 ·Status: COMPLETED
-
Genetic Mutation in Epithelial Ovarian Cancer
NCT04191252 ·Status: UNKNOWN
-
A Trial of Fast Access to Transvaginal Ultrasound Through General Practice for Earlier Diagnosis of Ovarian Cancer
NCT03069872 ·Status: COMPLETED ·Phase: NA
-
CA-125 in Screening Patients at High Risk for Ovarian Cancer
NCT00080639 ·Status: WITHDRAWN
-
Fermented Wheat Germ Extract in Women With Ovarian Cancer
NCT02411565 ·Status: TERMINATED ·Phase: EARLY_PHASE1